整形重建外科组织移植来源与开发:一项叙述性综述
该叙述性综述概述了整形与重建外科相关的同种异体和异种组织产品的现代来源、监管、加工和应用。同种异体组织通过全身或生殖组织捐献进入组织产业,自1997年起被FDA监管为HCT/Ps,组织库可自愿接受AATB监管;异种组织多源于猪或牛,受严格的动物育种和传染病筛查监管,基因编辑进展为异种器官移植带来可能。
要点
- 同种异体组织经全身或生殖组织捐献获取,自1997年起按HCT/Ps受FDA监管。
- 提供同种异体组织的组织库可自愿接受美国组织库协会(AATB)监管。
- 异种组织多源于猪或牛,受严格的动物育种和传染病筛查监管。
核心结论
- 本文概述了整形与重建外科领域组织产品的现代来源、监管、加工和应用。
研究设计与样本
- 叙述性综述,检索范围未在摘要中报告。
主要发现
- 同种异体组织通过全身捐献或生殖组织捐献进入组织产业,自1997年起被FDA监管为人类细胞、组织及细胞和组织基产品(HCT/Ps)。
- 提供同种异体组织的组织库可自愿接受美国组织库协会(AATB)监管。
- 制备用于移植的组织经灭菌后可加工为软组织或骨同种异体移植物用于手术重建,非移植组织则用于临床培训及药物、医疗器械和转化研究。
- 异种组织最常来源于猪或牛,同样商业可得,并受严格的动物育种和传染病筛查监管。
- 异种产品历史上经去细胞化处理用作非免疫原性组织产品,近期基因编辑进展为异种移植物器官移植入人类患者打开了大门。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The wealth of allogeneic and xenogeneic tissue products available to plastic and reconstructive surgeons has allowed for the development of novel surgical solutions to challenging clinical problems, often obviating the need to inflict donor site morbidity. Allogeneic tissue used for reconstructive surgery enters the tissue industry through whole body donation or reproductive tissue donation and has been regulated by the FDA as human cells, tissues, and cellular and tissue-based products (HCT/Ps) since 1997. Tissue banks offering allogeneic tissue can also undergo voluntary regulation by the American Association of Tissue Banks (AATB). Tissue prepared for transplantation is sterilized and can be processed into soft tissue or bone allografts for use in surgical reconstruction, whereas non-transplant tissue is prepared for clinical training and drug, medical device, and translational research. Xenogeneic tissue, which is most often derived from porcine or bovine sources, is also commercially available and is subject to strict regulations for animal breeding and screening for infectious diseases. Although xenogeneic products have historically been decellularized for use as non-immunogenic tissue products, recent advances in gene editing have opened the door to xenograft organ transplants into human patients. Herein, we describe an overview of the modern sourcing, regulation, processing, and applications of tissue products relevant to the field of plastic and reconstructive surgery.
引用
- Shih S, Askinas C, Caughey S, et al. Sourcing and development of tissue for transplantation in reconstructive surgery: A narrative review. J Plast Reconstr Aesthet Surg. 2023. PMID: 37279636. doi:10.1016/j.bjps.2023.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。